Abstract
Background Paget’s disease of the breast is an uncommon presentation of breast malignancy, accounting for 1–3% of all the breast tumors and presents in different histopathologic patterns: in association with an underlying invasive or non invasive carcinoma, or without any underlying neoplasia. In the literature, different methods are used for the treatment. Mastectomy with or without axillary dissection has been considered as the standard treatment procedure for many years. Several studies have already shown that breast conservation with radiation therapy is an oncologically safe option. Regarding the axillary approach, several studies have documented the presence of positive sentinel lymph node even in Paget’s disease alone. The objective of this study was to retrospectively analyze outcome of patients affected by Paget’s breast disease and to define our institutional experience. Patients and methods Between May 1996 and February 2003, 114 patients with confirmed Paget’s disease of the breast were retrieved and underwent surgery at the European Institute of Oncology of Milan, Italy. The median age of the patients was 54 years at the time of the diagnosis. In our study, the histopathological examination of the operated specimen revealed one hundred seven patients with Paget’s disease associated with an underlying invasive or non invasive carcinoma, and seven patients without underlying carcinoma. Patients underwent either conservative breast surgery or mastectomy, with or without sentinel lymph node biopsy and/or axillary surgery. Each patient was evaluated after surgery at a multidisciplinary meeting to selecting systemic therapy. Results Seven patients had “pure” Paget’s disease of the breast and one hundred seven had the disease associated with an underlying carcinoma. As surgical techniques 71 mastectomies and 43 breast conserving surgeries have been performed. Complete axillary dissection was done in patients with clinically positive lymph node and/or sentinel lymph node biopsy positive. Sentinel lymph node biopsy was performed in nineteen patients with invasive component and five were positive and underwent axillary dissection. Eleven sentinel lymph node biopsies were done in patients with non invasive component and none of them was positive. Adjuvant systemic therapies were based on the final tumor, node and metastasis stage: thirty patients received adjuvant chemotherapy alone, fourteen received endocrine treatment alone, twenty-six patients were evaluated to receive both chemo and endocrine therapy. The median duration of follow up was 73 months and was updated in the last 6 months. Five patients developed local recurrence, one had regional recurrence, another two had loco-regional recurrences and fourteen had distant metastasis as a first event. Malignancy-related deaths were censored in the statistical analyses cancer for and due to another tumor in eleven patients. Additionally, deaths were not related to malignancy totally in thirteen patients. Conclusions Screening examination and imaging techniques are fundamental. Breast conserving surgery combined with breast irradiation for patients with invasive and non invasive breast carcinoma has become the treatment of first choice. All surgical conservative approaches should include the complete nipple–areolar complex and margins of resected specimen free of tumor. Thanks to the evolution of the conservative approach, good cosmetic result can be obtained. To be informed about the axillary lymph node status and to avoid the patient to have a second surgical approach, sentinel lymph node biopsy should be performed.
Similar content being viewed by others
References
Velpeau A (1856) On disease of the mammary areola preceding cancer of the mammary region (trans: Mitchell H). Sydenham Society, London
Paget J (1874) On disease of the mammary areola preceding carcinoma of the mammary gland. St Bartholomews Hosp Rep 10:87–89
Ashikari R, Park K, Huvos AG, Urban JA (1970) Paget’s disease of the breast. Cancer 26:680–685
Chaudary MA, Millis RR, Lane EB, Miller NA (1986) Paget’s disease of the nipple: a ten-year review including clinical, pathological, and immunohistochemical findings. Breast Cancer Res Treat 8:139–146
Dixon AR, Galea MH, Ellis IO, Elston CW, Blamey RW (1991) Paget’s disease of the nipple. Br J Surg 78:722–723
Kothari AS, Beechey-Newman N, Hamed H, Fentiman IS, D’Arrigo C, Hanby AM (2002) Paget disease of the nipple: a multifocal manifestation of higher-risk disease. Cancer 95:1–7
Fu W, Mittel VK, Young SC (2001) Paget disease of the breast: analysis of 41 patients. Am J Clin Oncol 24:397–400
Bijker N, Rutgers EJ, Duchateau L, Peterse JL, Julien JP, Cataliotti L et al (2001) Breast-conservating therapy for Paget’s disease of the nipple. Cancer 91:472–477
Muir R (1935) Pathogenesis of Paget’s disease of the nipple and associated lesions. BR J Surg 22:728–737
Inglis K (1946) Paget’s disease of the nipple, with special reference to changes in the ducts. Am J Pathol 22:1–33
Yim JH, Wick MR, Philpott GW, Norton JA, Doherty GM (1997) Underlying pathology in mammary Paget’s disease. Ann Surg Oncol 4:287–292
Lagios MD, Westdahl PR, Rose MR, Concannon S (1984) Paget’s disease of the nipple. Alternative management in cases without or with minimal extent of underlying breast carcinoma. Cancer 54:545–551
Kollmorgen DR, Varanasi JS, Edge SB, Carson WE III (1998) Paget’s disease of the breast: a 33–year experience. J Am Coll Surg 187:171–177
Paone JF, Baker RR (1981) Pathogenesis and treatment of Paget’s disease of the breast. Cancer 48:825–829
Freud H, Maydovnik M, Laufer N, Durst A (1977) Paget’s disease of the breast. J Surg Oncol 9:93–98
Kawase K, Dimaio DJ, Tucker SL, Buchholz TA, Ross MI, Feig BW et al (2005) Paget’s disease of the breast: there is a role for breast-conserving therapy. Ann Surg Oncol 1:21–27
Chen C, Sun L, Anderson B (2006) Paget disease of the breast: changing patterns of incidence, clinical presentation, and treatment in the U.S. Cancer 107:1448–1458
Pierce LJ, Haffty BG, Solin LJ, McCormick B, Vicini FA, Wazer DE et al (1997) The conservative management of Paget’s disease of the breast with radiotherapy. Cancer 80:1065–1072
Joseph KA, Ditkoff BA, Estabrook A et al (2007) Therapeutic options for Paget’s disease: a single institution long-term follow-up study. Breast J 13(1):110–111
Sukumvanich P, Bentrem DJ, Cody HS et al (2007) The role of sentinel lymph node biopsy in Paget’s disease of the Breast. Ann Surg Oncol 14(3):1020–1023
Laronga C, Nasson D, Hoover S et al (2006) Paget’s disease in the era of sentinel lymph node biopsy. Am J Surg 192(4):481–483
Osther PJ, Balslev E, Blichert-Toft M (1990) Paget’s disease of the nipple. Acta Chir Scand 156:343–352
Jamali FR, Ricci A, Deckers PJ (1970) Paget’s disease of the breast. Am J Surg 76:365–381
Zakaria S, Pantvaidya G, Gosh K, Degnim AC (2007) Paget’s disease of the breast: accuracy of preoperative assessment. Breast Cancer Res Treat 102(2):137–142
Friedman EP, Hall-Craggs MA, Mumtaz H, Schneidau A (1997) Breast MR and the appearance of the normal and abnormal nipple. Clin Radiol 52:854–861
Soderstrom CE, Harms SE, Copit DS et al (1996) 3D RODEO breast MRI of lesions containing ductal carcinoma in situ. Radiology 201:427–432
Haerslev T, Krag JG (1992) Expression of citokeratin and erbB-2 oncoprotein in Paget’s disease of the nipple. An immunohistochemical study. APMIS 100:1041–1047
Wolber RA, Dupuis BA, Wick MR (1991) Expression of c-erb-B2 oncoprotein in mammary and extrammamary Paget’s disease. Am J Clin Pathol 96:243–247
Lammie GA, Barnes DM, Millis RR, Gullick WJ (1989) An immunohistochemical study of the presence of c-erbB-2 protein in Paget’s disease of the nipple. Histopathology 15:505–514
Winstanley J, Cooke T, Murray GD, Platt-Higgins A, George WD, Holt S et al (1991) The long term significance of c-erB-2 in primary breast cancer. Br J Cancer 63:447–450
McCann AH, Dervan PA, O’Regan M, Codd MB, Gullick WJ, Tobin BM et al (1991) Prognostic significance of c-erbB-2 and oestrogen receptor status in human breast cancer. Cancer Res 51:3296–3303
Lovekin C, Ellis IO, Locker A, Robertson JF, Bell J, Nicholson R et al (1991) c-erbB-2 oncoprotein expression in primary and advanced breast cancer. Br J Cancer 63:439–443
Polgar C, Orosz Z, Kovacs T, Fodor J (2002) Breast-conserving therapy for Paget disease of the nipple: a prospective European Organization for Research and Treatment of Cancer Study of 61 patients. Cancer 94:1904–1905
Stockdale AD, Brierley JD, White WF, Folkes A, Rostom AY (1989) Radiotherapy for Paget’s disease of the nipple: a conservative alternative. Lancet 2:664–666
Marshall JK, Griffith KA, Haffty BG, Solin LJ, Vicini FA, McCormick B et al (2003) Conservative management of Paget disease of the breast with radiotherapy: 10- and 15-year outcomes. Cancer 97(9):2142–2149
Fisher B, Anderson S, Bryant J et al (2002) Twenty-year follow-up randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation ort he treatment of invasive breast cancer. N Engl J Med 347:1233–1241
Shivers S, Cox C, Leight G et al (2002) Final results of the Department of Defense multicenter breast lymphatic mapping trial. Ann Surg Oncol 9:248–255
Lucci A Jr, Kelemen PR 3rd Miller C et al (2001) National practice patterns of sentinel lymph node dissection for breast carcinoma. J Am Coll Surg 192(4):453–458
Veronesi U, Paganelli G, Viale G et al (2003) A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer. N Engl J Med 349:546–553
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Caliskan, M., Gatti, G., Sosnovskikh, I. et al. Paget’s disease of the breast: the experience of the European institute of oncology and review of the literature. Breast Cancer Res Treat 112, 513–521 (2008). https://doi.org/10.1007/s10549-007-9880-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10549-007-9880-5